Search for: "Smith v. Merck" Results 41 - 60 of 87
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US:… [read post]
7 Sep 2011, 4:22 am by Marie Louise
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
25 Jan 2017, 10:48 pm
Researching the answer In KCI v Smith & Nephew [2010] EWHC 1487 (Pat), Arnold J held that information that would be acquired by the skilled person as a matter of routine can, in addition to CGK, be taken into account in considering inventive step. [read post]
13 Aug 2015, 10:56 am
Today we have a guest post (her second - she's a glutton for punishment) from fellow Reed Smith associate Danielle Devens. [read post]
6 Jan 2010, 6:00 am by Beck, et al.
Dec. 30, 2009) (applying Colorado law); Smith v. [read post]
5 Jul 2007, 10:37 am
Ortho Pharmaceutical Corp., 475 N.E.2d 65, 68 (Mass. 1985).Michigan: Smith v. [read post]
15 Jun 2011, 4:56 am by Marie Louise
Merck & Co Inc v Deutsches Patent- und Markenamt (The SPC blog) (The SPC blog) (The SPC blog) Monaco: Monaco, France and SPCs (The SPC blog) US: Supreme Court clarifies ownership rights in federally funded inventions under the Bayh-Dole Act: Stanford v. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic… [read post]
27 Jun 2011, 5:12 pm by Kevin LaCroix
Just last year the Court dealt with statute of limitations issues in the Merck case. [read post]